Hydrafacial Results Presentation Deck
2Q22 BALANCE SHEET HIGHLIGHTS
Cash and Cash Equivalents
Warrants
Convertible
Debt
Revolving Credit Facility
Shares Outstanding
Approximately $821.0 million cash and cash equivalents on balance sheet¹
Approximately 7.0 million Private Warrants outstanding
$750.0 million 1.25% convertible notes due 2026
Use of proceeds: capped call transaction, potential future acquisitions, working capital expenditures, and general
corporate purposes
Conversion price of $31.76; capped call agreement provides dilution protection up to $47.94
$50.0 million Senior Secured Credit Facility remains undrawn; current undrawn commitment fee of 25 bps
Allows flexibility for future M&A; ex-US operations unencumbered; convertible debt excluded from covenants
Approximately 150.9 million current shares outstanding2
Includes net proceeds of approximately $638.7 million convertible debt issued in September 2021, which have been and / or will be used to fund potential future acquisitions, working capital expenditures, a
capped call purchase agreement, and general corporate purposes
19
2 As of 08/05/22
♡ BEAUTYHEALTH™View entire presentation